Batt D G, Goodman R, Jones D G, Kerr J S, Mantegna L R, McAllister C, Newton R C, Nurnberg S, Welch P K, Covington M B
Inflammatory Diseases Research, Du Pont Merck Pharmaceutical Co., Wilmington, Delaware 19880-0353.
J Med Chem. 1993 May 14;36(10):1434-42. doi: 10.1021/jm00062a016.
A series of 2'-substituted chalcone derivatives has been found to show potent inhibition of the production of IL-1 beta from human peripheral blood monocytes stimulated with lipopolysaccharide (LPS), with IC50 values in the 0.2-5.0-microM range. Some members of the series have also shown inhibition of septic shock induced in mice by injection of LPS, although with low potency. Qualitative structure-activity relationships have shown that the enone is required for activity, which may be mediated by conjugate addition of a biological nucleophile to the chalcone. Electron-poor aromatic rings beta to the ketone give enhanced potency. Although electronic effects in the other ring (directly attached to the ketone) are minimal, this ring must possess an ortho substituent for good activity without cytotoxicity, suggesting a degree of selectivity which would not be expected for simple, nonspecific alkylating agents.
已发现一系列2'-取代查尔酮衍生物对脂多糖(LPS)刺激的人外周血单核细胞产生白细胞介素-1β具有强效抑制作用,IC50值在0.2-5.0微摩尔范围内。该系列的一些成员还显示出对注射LPS诱导的小鼠败血症休克有抑制作用,尽管效力较低。定性构效关系表明,活性需要烯酮,这可能是通过生物亲核试剂与查尔酮的共轭加成来介导的。酮β位的缺电子芳环可提高效力。虽然另一个环(直接连接到酮上)的电子效应最小,但该环必须具有邻位取代基才能具有良好的活性且无细胞毒性,这表明具有一定程度的选择性,而这对于简单的非特异性烷基化剂来说是无法预期的。